Method of treating cancer with a combination of an anti-CCR4 antibody and a 4-1BB agonist

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10023649
APP PUB NO 20170088627A1
SERIAL NO

15312515

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure describes combination therapies comprising an antibody which specifically binds to human CCR4 and a selective 4-1BB agonist, and the use of the combination therapies for the treatment of cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • PFIZER INC.; KYOWA HAKKO KIRIN CO., LTD.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Shihao Foster City, US 17 30
Healy, Denis Princeton, US 1 10
Lee, LiFen Palo Alto, US 1 10
Lin, Chia-Yang London, GB 47 97
Marshall, Margaret Princeton, US 1 10
Potluri, Shobha Foster City, US 2 10
Sawada, Naoki Tokyo, JP 52 364

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 17, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 17, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00